Zetiq, a fully-owned subsidiary of Micromedic Technologies Ltd., has developed CellDetect®, an innovative staining platform for early cancer detection. CellDetect® is the only histochemical assay allowing color discrimination alongside morphological examination for differentiation between normal and neoplastic cells.
 
For more information, please visit www.m-medic.com